276 U.S. Regional Differences in Psoriasis Care: Healthcare Utilization, Costs, and Access to Biologics

Journal of Investigative Dermatology - United Kingdom
doi 10.1016/j.jid.2019.03.352
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Timing of First-Time Use of Biologics and Healthcare Costs and Utilization in Psoriasis

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

267 Regional Disparities in Healthcare Utilization and Costs of Atopic Dermatitis

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

Global Variations in Biologics Access and Rheumatoid Arthritis Treatment Costs

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Regional Differences in the Prescription of Biologics for Psoriasis in Sweden: A Register-Based Study of 4168 Patients

BioDrugs
MedicineBiotechnologyPharmacology
2017English

Biologics in the Management of Psoriasis

Clinical, Cosmetic and Investigational Dermatology
Dermatology
2009English

Healthcare Costs Attributable to Secondhand Smoke Exposure at Home for U.S. Adults

Tobacco Induced Diseases
MedicineEnvironmentalPublic HealthHealthOccupational Health
2018English

Functional Status, Healthcare Utilization, and the Costs of Liver Transplantation

American Journal of Transplantation
TransplantationAllergyImmunologyPharmacology
2017English

Predicting Treatment Success With Biologics in Psoriasis

British Journal of Dermatology
DermatologyMedicine
2019English

Regional Differences Invalidate U.S. Sperm Trend Conclusions

Environmental Health Perspectives
MutagenesisPublic HealthEnvironmentalHealthToxicologyOccupational Health
1999English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy